Paper3210656
Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985.
Calavrezos A and 8 others. Klin Wochenschr, 1988. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985. Papers, record 3210656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3210656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesothelioma | Major topic |
| Pleural Neoplasms | Major topic |
| Adult | |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Combined Modality Therapy | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Pneumonectomy | |
| Prospective Studies | |
| Radiotherapy Dosage |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6174494 | Radiation therapy in the management of patients with mesothelioma. | Int J Radiat Oncol Biol Phys | 1982 | https://conductscience.org/library/papers/6174494 | PubMed |
| 2 | 3731150 | Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study. | Cancer Treat Rep | 1986 | https://conductscience.org/library/papers/3731150 | PubMed |
| 3 | 4831413 | [Retrospective study of 150 cases of mesothelioma in Hamburg area (author's transl)]. | Int Arch Arbeitsmed | 1974 | https://conductscience.org/library/papers/4831413 | PubMed |
| 4 | 309354 | Unexpected longevity of a patient with malignant pleural mesothelioma: report of a case. | Cancer | 1978 | https://conductscience.org/library/papers/309354 | PubMed |
| 5 | 948545 | The clinical aspects of mesothelioma. | Q J Med | 1976 | https://conductscience.org/library/papers/948545 | PubMed |
| 6 | 4040424 | Phase II trial of high-dose cisplatin in patients with malignant mesothelioma. | Cancer Treat Rep | 1985 | https://conductscience.org/library/papers/4040424 | PubMed |
| 7 | 359267 | Malignant mesothelioma. Current status and future prospects. | Chest | 1978 | https://conductscience.org/library/papers/359267 | PubMed |
| 8 | 6627213 | Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. | Cancer | 1983 | https://conductscience.org/library/papers/6627213 | PubMed |
| 9 | 1257933 | Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. | Thorax | 1976 | https://conductscience.org/library/papers/1257933 | PubMed |
| 10 | 826313 | Pleural mesothelioma. | Cancer | 1976 | https://conductscience.org/library/papers/826313 | PubMed |
| 11 | 6426072 | Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. | Thorax | 1984 | https://conductscience.org/library/papers/6426072 | PubMed |
| 12 | 7361805 | Multimodality therapy for malignant mesothelioma based on a study of natural history. | Am J Med | 1980 | https://conductscience.org/library/papers/7361805 | PubMed |
| 13 | 3335886 | Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3335886 | PubMed |
| 14 | 6177483 | [Malignant diffuse pleural mesothelioma therapy]. | Dtsch Med Wochenschr | 1982 | https://conductscience.org/library/papers/6177483 | PubMed |
| 15 | 6357260 | Malignant mesothelioma 1982: review of 4710 published cases. | Br J Dis Chest | 1983 | https://conductscience.org/library/papers/6357260 | PubMed |
| 16 | 7091938 | Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/7091938 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24868442 | Management of malignant pleural mesothelioma-The European experience. | J Thorac Dis | 2014 | https://conductscience.org/library/papers/24868442 | PubMed |
| 21534090 | Factors that impact susceptibility to fiber-induced health effects. | J Toxicol Environ Health B Crit Rev | 2011 | https://conductscience.org/library/papers/21534090 | PubMed |
| 20672705 | Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis. | Zhongguo Fei Ai Za Zhi | 2010 | https://conductscience.org/library/papers/20672705 | PubMed |
| 16856023 | Radiotherapy for malignant pleural mesothelioma. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/16856023 | PubMed |
| 12947146 | Lung cancer * 8: Management of malignant mesothelioma. | Thorax | 2003 | https://conductscience.org/library/papers/12947146 | PubMed |
| 8826866 | Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8826866 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3210656
GET https://conductscience.org/api/papers/v1/3210656/authors